A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding. (2014)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.celrep.2014.07.020
PubMed Identifier: 25131200
Publication URI: http://europepmc.org/abstract/MED/25131200
Type: Journal Article/Review
Volume: 8
Parent Publication: Cell reports
Issue: 4